Literature DB >> 3020049

A calcium-dependent 35-kilodalton substrate for epidermal growth factor receptor/kinase isolated from normal tissue.

B K De, K S Misono, T J Lukas, B Mroczkowski, S Cohen.   

Abstract

We have previously reported the isolation of a 35-kDa protein from A-431 cells that, in the presence of Ca2+, can serve as a substrate for the epidermal growth factor (EGF) receptor/tyrosine kinase (Fava, R.A., and Cohen, S. (1984) J. Biol. Chem. 259, 2636-2645). We now report the detection of an antigenically related 35-kDa protein in a number, but not all, of rat, pig, and human tissues. These antigenically related proteins also can serve as substrates for the EGF receptor/kinase in the presence of Ca2+. All of these proteins share the property of reversible, Ca2+-dependent binding to the particulate fraction (presumably membranes) of cell homogenates. We have isolated the 35-kDa substrate from porcine lung and have demonstrated that it is a Ca2+-binding protein. The amino-terminal sequence and the site of tyrosine phosphorylation therein have been determined. The positions of the acidic amino acid residues amino-terminal to the tyrosine phosphorylation site bear a distinct resemblance to the sequence in the homologous region of a number of other substrates for tyrosine kinases. Based on available data, the 35-kDa protein clearly differs from the protein I complex derived from intestinal mucosa and thought to be related to the proteins isolated herein (Gerke, V., and Weber, K. (1985) J. Biol. Chem. 260, 1688-1695). Finally, we report a striking sequence homology between the porcine 35-kDa described herein and human lipocortin, a phospholipase A2 inhibitor.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3020049

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

Review 1.  Monoclonal antibodies to epidermal growth factor receptors in studies of receptor structure and function.

Authors:  T Kawamoto; G H Sato; K Takahashi; M Nishi; S Taniguchi; J D Sato
Journal:  Cytotechnology       Date:  1990-05       Impact factor: 2.058

2.  Macrophage surface expression of annexins I and II in the phagocytosis of apoptotic lymphocytes.

Authors:  Xiaoxuan Fan; Stephen Krahling; Douglas Smith; Patrick Williamson; Robert A Schlegel
Journal:  Mol Biol Cell       Date:  2004-04-02       Impact factor: 4.138

3.  Origins of growth factors: NGF and EGF.

Authors:  Stanley Cohen
Journal:  J Biol Chem       Date:  2008-08-12       Impact factor: 5.157

4.  Purification and partial sequence analysis of plant annexins.

Authors:  M Smallwood; J N Keen; D J Bowles
Journal:  Biochem J       Date:  1990-08-15       Impact factor: 3.857

5.  Identification of the 32 kDa components of bovine lens EDTA-extractable protein as endonexins I and II.

Authors:  R Kobayashi; R Nakayama; A Ohta; F Sakai; S Sakuragi; Y Tashima
Journal:  Biochem J       Date:  1990-03-01       Impact factor: 3.857

6.  A dimeric form of lipocortin-1 in human placenta.

Authors:  R B Pepinsky; L K Sinclair; E P Chow; B O'Brine-Greco
Journal:  Biochem J       Date:  1989-10-01       Impact factor: 3.857

7.  Recombinant human epidermal growth factor precursor is a glycosylated membrane protein with biological activity.

Authors:  B Mroczkowski; M Reich; K Chen; G I Bell; S Cohen
Journal:  Mol Cell Biol       Date:  1989-07       Impact factor: 4.272

8.  Synthesis of p36 and p35 is increased when U-937 cells differentiate in culture but expression is not inducible by glucocorticoids.

Authors:  C M Isacke; R A Lindberg; T Hunter
Journal:  Mol Cell Biol       Date:  1989-01       Impact factor: 4.272

9.  Regulation of calpactin I phospholipid binding by calpactin I light-chain binding and phosphorylation by p60v-src.

Authors:  M A Powell; J R Glenney
Journal:  Biochem J       Date:  1987-10-15       Impact factor: 3.857

10.  Human 67-kDa calelectrin contains a duplication of four repeats found in 35-kDa lipocortins.

Authors:  T C Südhof; C A Slaughter; I Leznicki; P Barjon; G A Reynolds
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.